Reagents and high-purity lab chemicals: Production
The Covid sales boom and the destocking that followed
What this tab covers Who makes it and how much: world capacity and output, utilisation, the top producing countries and companies globally and in India, concentration, new capacity coming, and each region's position.| Measure | Figure | Detail | Source |
|---|---|---|---|
| World capacity | not published | no public total | |
| World output | not published | no public total | |
| Capacity utilisation | not published | Suppliers saw a Covid-era boom in 2020-2022, then destocking by bioprocessing and pharma customers in 2023-2024 (indicative). | indicative |
| Concentration | top five suppliers about 38-44% of revenue (MRFR 2025) | Estimated shares: Merck KGaA 9-12%, Thermo Fisher 8-11%, Avantor 5-8%, Honeywell Research Chemicals 4-6%, BD 3-5%, Bio-Rad 3-5%, Danaher 3-5%, Revvity 2-4%, FUJIFILM Wako 2-3%, TCI 1-3%. Figures are by demand region; production location is not published. | Market Research Future (2026) |
| New capacity | not published | Growth is in biochemistry and pharma QC reagents and in Asia-Pacific (MRFR); Indian makers are adding HPLC and LC-MS solvent and biochemical lines (indicative). | MRFR (2026); indicative |
Top producing countries
United States 32% · North America 31.9% of 2025 revenue; US 78.4% of that (MRFR) Europe (Germany 23.6% of region) 28% · $8.49 billion (2025, MRFR) Asia-Pacific (China 38.2% of region) 27% · fastest growing at 5.03% a year (MRFR); share derived as remainder of over 86% for the three regions (indicative) South America (Brazil 56.3% of region) 7% · $2.16 billion (2025, MRFR) Middle East and Africa 6% · growing 3.87% a year (MRFR); share derived Market Research Future (2026); Market Research Future (2026); share derivedLargest producers: global
| Company | Country | Volume | Year | Source |
|---|---|---|---|---|
| Merck KGaA (MilliporeSigma, Sigma-Aldrich) largest catalogue of research chemicals | Germany | not published | 2025 | MRFR (2026): about 9-12% |
| Thermo Fisher Scientific Fisher Chemical, Alfa Aesar, Invitrogen brands; group revenue about $42.9 billion in 2024 (indicative) | US | not published | 2025 | MRFR (2026): about 8-11% |
| Avantor (VWR, J.T.Baker) revenue $6.78 billion (2024) and $6.55 billion (2025) (Avantor full-year 2025 results); owns RFCL in India (indicative) | US | not published | 2025 | MRFR (2026): about 5-8% |
| Honeywell Research Chemicals Riedel-de Haen and Burdick & Jackson solvents (indicative) | US/Germany | not published | 2025 | MRFR (2026): about 4-6% |
| FUJIFILM Wako Pure Chemical Japanese reagent leader | Japan | not published | 2025 | MRFR (2026): about 2-3% |
| Tokyo Chemical Industry (TCI) organic research reagents | Japan | not published | 2025 | MRFR (2026): about 1-3% |
| Bio-Rad Laboratories life science and clinical reagents | US | not published | 2025 | MRFR (2026): about 3-5% |
Largest producers: India
| Company | Country | Volume | Year | Source |
|---|---|---|---|---|
| Sisco Research Laboratories (SRL) private; laboratory and biochemical reagents (indicative) | India | not published | 2025 | company (indicative) |
| Loba Chemie private; laboratory reagents and fine chemicals (indicative) | India | not published | 2025 | company (indicative) |
| Spectrochem private; reagents and HPLC solvents (indicative) | India | not published | 2025 | company (indicative) |
| Thomas Baker (Chemicals) private; laboratory chemicals (indicative) | India | not published | 2025 | company (indicative) |
| RFCL (Avantor India) ex-Ranbaxy Fine Chemicals (Rankem), acquired by Avantor (indicative) | India | not published | 2025 | indicative |
India has many private reagent makers for laboratory and analytical grades, while high-end biochemicals, reference standards and LC-MS solvents are mostly imported from Merck, Thermo Fisher and others (indicative). Production figures are not published.
Position by region
| Region | Position |
|---|---|
| US | Largest market; US federal research funding changes in 2025 weighed on academic demand (indicative). |
| EU | Germany is 23.6% of European demand (MRFR); REACH and CLP labelling for all packs. |
| India | Pharma QC and contract research drive demand; import dependence for high-end grades (indicative). |
| China | 38.2% of Asia-Pacific demand (MRFR); domestic makers such as Sinopharm Chemical Reagent compete on price (indicative). |
| Japan | FUJIFILM Wako, TCI and Kanto Chemical lead (indicative). |
| Middle East | Saudi Arabia 28.7% of Middle East and Africa demand (MRFR). |